Drug Shortage Report for IFEX
Report ID | 103465 |
Drug Identification Number | 02241356 |
Brand name | IFEX (IFOSFAMIDE) 3 G/VIAL |
Common or Proper name | IFEX (IFOSFAMIDE) 3 G/VIAL |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | IFOSFAMIDE |
Strength(s) | 3G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 3g vial |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-01-16 |
Actual start date | 2020-01-16 |
Estimated end date | 2020-02-04 |
Actual end date | 2020-02-04 |
Shortage status | Resolved |
Updated date | 2020-02-05 |
Company comments | Customers can choose the alternate format of IFEX 1G if it fits their clinical need. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-01-16 | English | Compare |
v2 | 2020-01-16 | French | Compare |
v3 | 2020-01-17 | English | Compare |
v4 | 2020-02-04 | English | Compare |
v5 | 2020-02-04 | French | Compare |
v6 | 2020-02-05 | English | Compare |
Showing 1 to 6 of 6